NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Ensysce Biosciences, Inc. Common Stock Share Price Chart

O H L

Ensysce Biosciences, Inc. Common Stock Performance Overview

Days Range
$0.46Low
$0.46High

Markets Today

Previous Close$0.45
Open$0.46
Volume391,138
Day's Range$0.46 - $0.46
52W Range$0.23 - $2.75
Market Cap$8.71 M

Historical Performance

1M Returns+17.53
3M Returns+66.79
6M Returns-28.32
1Y Returns-78.45
5Y Returns-100.00
10Y ReturnsNA

Ensysce Biosciences, Inc. Common Stock Fundamentals

Market Cap$8.71 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$5.07 M
ROE TTM-2.94
EPS TTM$-2.75
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-10.23 M
Profit Margin-200.84
Market Cap$8.71 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$5.07 M
ROE TTM-2.94
EPS TTM$-2.75
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-10.23 M
Profit Margin-200.84

Ensysce Biosciences, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$1.32 M$1.37 M$493.10 K$1.88 M$961.00 K$1.16 M
Gross Profit +$1.32 M$1.37 M$493.10 K$1.88 M$961.00 K$1.16 M
Operating Income -$1.97 M-$1.75 M-$3.74 M-$2.78 M-$3.56 M-$2.58 M
EBITDA -$1.97 M-$1.75 M-$3.74 M-$2.78 M-$3.56 M-$2.57 M
Interest Expense -$3.86 K-$3.16 K-$6.37 K-$5.38 K-$3.92 K-$320
Depreciation $0$0$0$6.53 K$6.53 K$6.53 K
Income Before Tax -$1.95 M-$1.73 M-$3.73 M-$2.77 M-$3.56 M-$2.57 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$1.95 M-$1.73 M-$3.73 M-$2.77 M-$3.56 M-$2.57 M
Net Profit Margin -147.42%-126.4%-756.26%-147.05%-370.07%-220.81%

Ensysce Biosciences, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $165$241$320$459$929$1.62 K
Reserve & Surplus -$131.49 M-$133.22 M-$136.95 M-$139.72 M-$143.28 M-$145.85 M
Non-Current Liabilities $130.18 K$1.03 K$35$0$0$0
Current Liabilities $1.76 M$2.51 M$2.30 M$4.57 M$2.84 M$4.07 M
Total Liabilities $1.89 M$2.51 M$2.30 M$4.57 M$2.84 M$4.07 M
Fixed Assets $0$0$123.64 K$124.13 K$117.60 K$111.06 K
Current Assets $4.40 M$5.28 M$2.93 M$7.25 M$2.01 M$2.85 M
Total Assets $4.61 M$5.57 M$3.18 M$7.45 M$2.17 M$2.96 M

Ensysce Biosciences, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$1.95 M-$1.73 M-$3.73 M-$2.77 M-$3.56 M-$2.57 M
Operating Cash Flow -$1.71 M-$2.71 M-$1.87 M-$1.53 M-$3.50 M-$1.96 M
Investing Cash Flow $0$0-$123.64 K$0$0$0
Financing Cash Flow $1.26 M$1.87 M$1.45 M$4.16 M-$63.95 K$1.89 M
Change in Cash -$449.59 K-$840.92 K-$538.36 K$2.64 M-$3.56 M-$68.78 K

Ensysce Biosciences, Inc. Common Stock Return Calculator

The Ensysce Biosciences, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$0
Invested Amount$10,000
Est. Returns$-10,000
Invest in USA Stock Today

About Ensysce Biosciences, Inc. Common Stock

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

FAQs

Ensysce Biosciences, Inc. Common Stock (ENSC) share price as of September 18, 2026 is $0.45. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Ensysce Biosciences, Inc. Common Stock (ENSC) Share by opening an international trading account with Angel One.
Purchasing Ensysce Biosciences, Inc. Common Stock (ENSC) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Ensysce Biosciences, Inc. Common Stock (ENSC) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Ensysce Biosciences, Inc. Common Stock (ENSC) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Ensysce Biosciences, Inc. Common Stock on September 18, 2026, is $8.71 M.
Ensysce Biosciences, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Ensysce Biosciences, Inc. Common Stock (ENSC) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91